Hiroshi Katayama

Principal Reviewer
Pharmaceuticals and Medical Devices Agency

Dr. Katayama is a principal reviewer for Office of Medical Devices I in Pharmaceuticals and Medical Devices Agency (PMDA). His work has focused on the clinical trial methodology, the study and treatment of gastric, esophageal, colon and colorectal cancers, and he has authored and co-authored numerous publications on his work. He received his medical degree from the University of Mie, Mie prefecture, Japan, and is board-certified in general surgery, laparoscopic surgery – stomach, and general clinical oncology.

Presentation(s):

• Panel Discussion – What Steps Can Be Taken to Minimize the Impact of Future Disruptions to Global Clinical Studies?

  Monday, February 27, 2023
  9:50 AM – 10:15 AM ET

  Disclosure information not submitted.

• Real-World Use of Clinical Decision Support Software – Is it “Supporting” or “Deciding”?

  Monday, February 27, 2023
  11:05 AM – 11:15 AM ET

  Disclosure information not submitted.

• Panel discussion – What are the Potential Barriers to Multinational Regulation of Novel Digital Health Products and How can we Address Them?

  Monday, February 27, 2023
  11:15 AM – 11:50 AM ET

  Disclosure information not submitted.